Stavroula Baritaki
Stavroula Baritaki
Asst. Professor of Experimental Oncology, Medical School, University of Crete
Verified email at uoc.gr
Title
Cited by
Cited by
Year
Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer
G Ren, S Baritaki, H Marathe, J Feng, S Park, S Beach, PS Bazeley, ...
Cancer research 72 (12), 3091-3104, 2012
2012012
Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials
B C Potts, M X Albitar, K C Anderson, S Baritaki, C Berkers, B Bonavida, ...
Current cancer drug targets 11 (3), 254-284, 2011
2002011
Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP …
S Baritaki
Oncogene, 2009
1702009
Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1
S Baritaki, S Huerta-Yepez, T Sakai, DA Spandidos, B Bonavida
Molecular cancer therapeutics 6 (4), 1387-1399, 2007
1582007
Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo-and immunosensitization to apoptosis and inhibition of metastases
B Bonavida, S Baritaki, S Huerta-Yepez, MI Vega, D Chatterjee, K Yeung
Nitric oxide 19 (2), 152-157, 2008
1482008
The role of B-RAF mutations in melanoma and the induction of EMT via dysregulation of the NF-κB/Snail/RKIP/PTEN circuit
K Lin, S Baritaki, L Militello, G Malaponte, Y Bevelacqua, B Bonavida
Genes & cancer 1 (5), 409-420, 2010
1422010
Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up …
S Baritaki, A Katsman, D Chatterjee, KC Yeung, DA Spandidos, ...
The Journal of Immunology 179 (8), 5441-5453, 2007
1302007
Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry
B Bonavida, S Baritaki
Nitric Oxide 24 (1), 1-7, 2011
1162011
VEGF, FGF2, TGFB1 and TGFBR1 mRNA expression levels correlate with the malignant transformation of the uterine cervix
G Soufla, S Sifakis, S Baritaki, A Zafiropoulos, E Koumantakis, ...
Cancer letters 221 (1), 105-118, 2005
1102005
Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization
S Baritaki, K Yeung, M Palladino, J Berenson, B Bonavida
Cancer research 69 (21), 8376-8385, 2009
1002009
Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1
S Huerta-Yepez, M Vega, SE Escoto-Chavez, B Murdock, T Sakai, ...
Nitric Oxide 20 (1), 39-52, 2009
972009
Overexpression of VEGF and TGF-β1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: implication of YY1 in cervical tumorigenesis …
S Baritaki, S Sifakis, S Huerta-Yepez, IK Neonakis, G Soufla, B Bonavida, ...
International journal of oncology 31 (1), 69-79, 2007
952007
Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease
S Apostolakis, S Baritaki, GE Kochiadakis, NE Igoumenidis, ...
Thrombosis research 119 (1), 63-71, 2007
952007
Mechanisms of nitric oxide-mediated inhibition of EMT in cancer: inhibition of the metastasis-inducer Snail and induction of the metastasis-suppressor RKIP
S Baritaki, S Huerta-Yepez, A Sahakyan, I Karagiannides, K Bakirtzi, ...
Cell cycle 9 (24), 4931-4940, 2010
912010
A novel anticancer effect of butein: inhibition of invasion through the ERK1/2 and NF-κB signaling pathways in bladder cancer cells
LR Zhang, W Chen, X Li
FEBS letters 582 (13), 1821-1828, 2008
892008
The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-κB/Snail/YY1/RKIP/PTEN Circuitry
B Bonavida, S Baritaki
Critical Reviews™ in Oncogenesis 16 (3-4), 2011
872011
Inhibition of Yin Yang 1-dependent repressor activity of DR5 transcription and expression by the novel proteasome inhibitor NPI-0052 contributes to its TRAIL-enhanced apoptosis …
S Baritaki, E Suzuki, K Umezawa, DA Spandidos, J Berenson, TR Daniels, ...
The Journal of Immunology 180 (9), 6199-6210, 2008
852008
TRAF6 activation in multiple myeloma: a potential therapeutic target
H Liu, S Tamashiro, S Baritaki, M Penichet, Y Yu, H Chen, J Berenson, ...
Clinical Lymphoma Myeloma and Leukemia 12 (3), 155-163, 2012
802012
Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
AS P Kanellou, A Zaravinos, M Zioga
Cancer letters, 2008
792008
Reversal of tumor resistance to apoptotic stimuli by alteration of membrane fluidity: therapeutic implications
S Baritaki, S Apostolakis, P Kanellou, MT Dimanche‐Boitrel, ...
Advances in cancer research 98, 149-190, 2007
792007
The system can't perform the operation now. Try again later.
Articles 1–20